Chemical and Pharmaceutical Bulletin · 2010 · 44 citations · 47 references
MedicineMedicinal ChemistryPharmacologyGeneral PharmacologyNeuropharmacologyPsychopharmacologyNeurochemical PharmacologyNeuroprotectionNeuroprotective PharmacologyAnticonvulsant ActionAnticonvulsant DrugsIntraperitoneal AdministrationNeuroprotective AgentsNeuroprotective MechanismsReference StandardsSeizuresTonic Seizures
Synthesis of furochromone, 2-phenylchromone (flavone) and benzofuran derivatives substituted with thiosemicarbazide or thiazolidin-4-one moieties were accomplished. All the newly synthesized compounds were tested for their anticonvulsant activity in both subcutaneous pentylenetetrazole induced seizures (scPTZ) and maximal electric shock induced seizures (MES) tests using valproic acid and phenytoin respectively as reference standards. The most active compounds in scPTZ model were 1c, 2b, 5a and 7e showing 100% protection at 300 mg/kg upon intraperitoneal administration. Also, the effect of pre-treatment of three of the most active compounds (1c, 2b, 5a) on 4-amino pyridine-induced lethality in mice was investigated. Pre-treatment with these compounds significantly increased the latency for clonic and tonic seizures and prevented 4-amino pyridine induced death. Hence, this provides evidence for anticonvulsant activity of these compounds, and a neuroprotective activity for them. The structure-activity relationship was studied based on the obtained data.
47
Goodman and Gilman's the Pharmacological Basis of Therapeutics
William H. Stigelman, D Pharm · Military Medicine · 1986 · 6.8K citations
Early Identification of Refractory Epilepsy
Patrick Kwan, Martin J. Brodie · New England Journal of Medicine · 2000 · 5.2K citations · Full text
Medicine, Neurology, Pharmacotherapy +17
Antiepileptic Drug Development: II. Anticonvulsant Drug Screening
Ronald L Krall, J. K. Penry, B. G. White et al. · Epilepsia · 1978 · 823 citations